Arrhythmia Monitoring Devices Market To Reach $12.03 Billion By 2030

Arrhythmia Monitoring Devices Market Growth & Trends

The global arrhythmia monitoring devices market size is expected to reach USD 12.03 billion in 2030 with a CAGR of 7.4% during the forecast period, according to a new report by Grand View Research, Inc. Continuous R&D activities in the field of cardiac monitoring are leading to technological expansion. This, in turn, is positively influencing the growth of the arrhythmia monitoring devices market. Wearable diagnostic patch by iRhythm Technologies, Inc., Zio, has led to symptomatic arrhythmia monitoring, which is superior in comparison to conventional Holter monitors.

Big pharma and medical device companies are heavily investing in R&D to perform a detailed mapping of cardiac arrhythmia. In February 2018, Medtronic received FDA clearance for the first non-invasive cardiac mapping system, CardioInsight. It includes wearable 252-electrode sensor vest that creates 3D electroanatomic maps of heart by combining data from a cardiac computed tomography scan with ECG signals collected from the chest region.

In addition to these technologies, emergence and advancements in mobile cardiac telemetry are leading to further progress of the overall market. In October 2017, Abbott received FDA clearance for Confirm Rx, a smartphone-compatible implantable cardiac monitor indicated for arrhythmia diagnosis. Boston Scientific announced its FDA approval for Resonate, a line of cardiac resynchronization therapy defibrillator and cardioverter defibrillator systems for the cardiac management.

 Request a free sample copy or view report summary: Arrhythmia Monitoring Devices Market Report

Arrhythmia Monitoring Devices Market Report Highlights

• Holter monitors dominated the market in terms of revenue in 2023. On the other hand, mobile cardiac telemetry is expected to witness the fastest growth rate during the forecast period

• Atrial fibrillation dominated the market in terms of revenue in 2023. The growth in the number of untreated cases of arrhythmias are leading to increasing need for advanced cardiac monitoring devices

• Heightened adoption of sophisticated technologies has led to the expansion of the market. Kardia Mobile by AliveCor captures ECG in 30 seconds projecting the heart rhythm for conditions such as atrial fibrillation

• The hospitals and clinics segment held the largest share in the market in 2023. On the other hand, diagnostic centers are likely to experience the fastest growth over the forecast period

Arrhythmia Monitoring Devices Market Segmentation

Grand View Research has segmented the global arrhythmia monitoring devices market report based on type, application, end-use, and region:

Arrhythmia Monitoring Devices Type Outlook (Revenue, USD Million, 2018 - 2030)

• ECG Monitors

• Implantable Monitors

• Holter Monitors

• Mobile Cardiac Telemetry

Arrhythmia Monitoring Devices Application Outlook (Revenue, USD Million, 2018 - 2030)

• Bradycardia

• Tachycardia

• Atrial Fibrillation

• Ventricular Fibrillation

• Premature Contraction

• Others

Arrhythmia Monitoring Devices End-Use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals and Clinics

• Ambulatory Centers

• Diagnostic Centers

• Others

Arrhythmia Monitoring Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Arrhythmia Monitoring Devices Market

• Abbott

• ACS Diagnostics

• GE HeathCare

• Biotronik

• iRhythm Technologies, Inc.

• Medtronic

• Koninklijke Philips N.V.

• FUKUDA DENSHI

• Spacelabs Healthcare

• AliveCor, Inc.